Abstract
In the United States, veterinary use of mupirocin is primarily limited to the treatment of canine pyoderma caused by methicillin-resistant Staphylococcus pseudintermedius (MRSP). In this study, only 1 of 581 S. pseudintermedius isolates tested was resistant to mupirocin and carried the high-level mupirocin resistance gene, ileS2, on a plasmid.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Bacterial Agents / pharmacology*
-
DNA, Bacterial / chemistry
-
DNA, Bacterial / genetics
-
Dogs
-
Drug Resistance, Bacterial*
-
Genes, Bacterial
-
Molecular Sequence Data
-
Mupirocin / pharmacology*
-
Polymerase Chain Reaction
-
Prevalence
-
Pyoderma / microbiology
-
Pyoderma / veterinary
-
Sequence Analysis, DNA
-
Staphylococcal Infections / microbiology
-
Staphylococcal Infections / veterinary
-
Staphylococcus / drug effects*
-
Staphylococcus / genetics
-
Staphylococcus / isolation & purification
-
United States
Substances
-
Anti-Bacterial Agents
-
DNA, Bacterial
-
Mupirocin
Associated data
-
GENBANK/KJ000544
-
GENBANK/KJ000545
-
GENBANK/KJ000546
-
GENBANK/KJ000547
-
RefSeq/NG_041749